{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:18:34Z","timestamp":1789885114312,"version":"4.0.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.vaccine.2013.04.050","type":"journal-article","created":{"date-parts":[[2013,5,9]],"date-time":"2013-05-09T14:00:43Z","timestamp":1368108043000},"page":"3025-3033","source":"Crossref","is-referenced-by-count":72,"title":["Safety and immunogenicity of IMVAMUNE\u00ae smallpox vaccine using different strategies for a post event scenario"],"prefix":"10.1016","volume":"31","author":[{"given":"Sharon E.","family":"Frey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia L.","family":"Winokur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Salata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer S.","family":"El-Kamary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine B.","family":"Turley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Emmanuel B.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine Mhorag","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances K.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather R.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Chaplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Tary-Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Belshe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.04.050_bib0005","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3201\/eid0504.990413","article-title":"Vaccines in civilian defense against bioterrorism","volume":"5","author":"Russel","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.050_bib0010","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1126\/science.283.5406.1279","article-title":"The looming threat of bioterrorism","volume":"283","author":"Henderson","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2013.04.050_bib0015","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1016\/j.vaccine.2005.01.079","article-title":"A novel, cell culture-derived smallpox vaccine in vaccinia-na\u00efve adults","volume":"23","author":"Artenstein","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.050_bib0020","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.ijid.2004.09.002","article-title":"ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain) \u2013 a second-generation smallpox vaccine for biological defense","volume":"8S2","author":"Monath","year":"2004","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.050_bib0025","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.vaccine.2008.11.079","article-title":"Comparison of the safety and immunogenicity of ACAM1000 ACAM2000 and Dryvax\u00ae in healthy vaccinia-na\u00efve adults","volume":"27","author":"Frey","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.050_bib0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01641272","article-title":"Passage history, properties, and applicability of the attenuated vaccinia virus strain MVA","volume":"3","author":"Mayr","year":"1975","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2013.04.050_bib0035","first-page":"283","article-title":"An attenuated strain of vaccinia virus (MVA). Successful intramuscular immunization against vaccinia and variola","volume":"230","author":"Hochstein-Mintzel","year":"1975","journal-title":"Zentralbl Bakteriol"},{"key":"10.1016\/j.vaccine.2013.04.050_bib0040","first-page":"24","article-title":"Changes in the vaccinia virus through continuing passages in chick embryo fibroblast cultures","volume":"195","author":"Mayr","year":"1964","journal-title":"Zentralbl Bakteriol"},{"key":"10.1016\/j.vaccine.2013.04.050_bib0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0091-7435(74)90066-8","article-title":"Smallpox vaccination and its consequences: first experiences with the highly attenuated smallpox vaccine MVA","volume":"3","author":"Stickl","year":"1974","journal-title":"Prev Med"},{"key":"10.1016\/j.vaccine.2013.04.050_bib0050","first-page":"375","article-title":"The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism","volume":"167","author":"Mayr","year":"1978","journal-title":"Zentralbl Bakteriol"},{"key":"10.1016\/j.vaccine.2013.04.050_bib0055","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.vaccine.2009.11.030","article-title":"A randomized, double-blind, dose-finding phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE\u00ae","volume":"28","author":"Von Krempelhuber","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.050_bib0060","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.1016\/j.vaccine.2007.10.017","article-title":"Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge","volume":"25","author":"Frey","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.050_bib0065","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1086\/651560","article-title":"Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax","volume":"201","author":"Seaman","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.050_bib0070","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1128\/JCM.41.7.3154-3157.2003","article-title":"Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine","volume":"41","author":"Newman","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.050_bib0075","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1001\/jama.289.24.3295","article-title":"Response to smallpox vaccine in persons immunized in the distant past","volume":"289","author":"Frey","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2013.04.050_bib0080","doi-asserted-by":"crossref","first-page":"3723732","DOI":"10.4049\/jimmunol.164.7.3723","article-title":"Direct visualization of cytokine producing recall antigen specific memory T cells in HIV patients and healthy individuals","volume":"164","author":"Helms","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.04.050_bib0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1086\/595565","article-title":"Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox","volume":"199","author":"Paran","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.050_bib0090","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1099\/vir.0.010553-0","article-title":"Evaluation of smallpox vaccines using variola neutralization","volume":"90","author":"Damon","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2013.04.050_bib0095","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1128\/CVI.00056-12","article-title":"Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines","volume":"19","author":"Hughes","year":"2012","journal-title":"Clin Vaccine Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13005185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13005185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T23:58:28Z","timestamp":1539647908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13005185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":19,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0264410X13005185"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.04.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}